이재훈 프로필 사진

이재훈

Jae Hoon, Lee

의과대학

의학과

자료 필터

자료유형

발행연도

2012 ~ 2026
2012 2026

키워드

언어

전체 115건 중 1번부터 10번까지의 결과를 표시합니다.

2026
Article

Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea

  • 이준호
  • 이재훈
  • 정성훈
  • 이지현
  • 이지윤
  • 외 7명
  • 2026-07
  • Cancer Research and Treatment
  • 대한암학회
Article

Response kinetics as a dynamic prognostic marker in patients with multiple myeloma

  • Cho, Hee Jeong
  • Lee, Myung-Won
  • Lee, Jae Hoon
  • Eom, Hyeon-Seok
  • Jung, Jongheon
  • 외 16명
  • 2026-07
  • Leukemia
  • SPRINGERNATURE
Article

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma

  • Kumar, Shaji
  • Jagannath, Sundar
  • Weisel, Katja C.
  • Rosinol, Laura
  • Leleu, Xavier
  • ... Lee, Jae Hoon
  • 외 37명
  • 2026-03
  • Blood Cancer Journal
  • SPRINGERNATURE
Article

A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)

  • Jung, Sung-Hoon
  • Kim, Dajung
  • Lee, Je-Jung
  • Kim, Kihyun
  • Min, Chang-Ki
  • ... Lee, Jae Hoon
  • 외 8명
  • 2026-02
  • British Journal of Haematology
  • WILEY
Article

Carfilzomib, pomalidomide, and dexamethasone for multiple myeloma after carfilzomib, lenalidomide, and dexamethasone

  • Yi, Jun Ho
  • Park, Sung-Soo
  • Min, Chang-Ki
  • Lee, Jae Hoon
  • Eom, Hyeon-Seok
  • 외 2명
  • 2026-01
  • International Journal of Hematology
  • SPRINGER JAPAN KK
2025
Article

Rusfertide rapidly decreases hematocrit in patients with suboptimally controlled polycythemia vera

  • Chew, Lee Ping
  • Ginzburg, Yelena Z.
  • Kirubamoorthy, Kamini
  • Lee, Sung-Eun
  • Lee, Jae Hoon
  • 외 6명
  • 2025-12
  • Leukemia Research
  • PERGAMON-ELSEVIER SCIENCE LTD
Article

A phase 1/2a trial of amsulostat, a novel pan-lysyl oxidase inhibitor, in patients with advanced myelofibrosis as an add-on to ruxolitinib treatment for up to 52 weeks

  • Baker, Ross
  • Chen, Chih-Cheng
  • Chen, Tsai-Yun
  • Cheung, Stanley
  • Hsiao, Hui-Hua
  • ... Lee, Jae Hoon
  • 외 12명
  • 2025-11
  • Blood
  • ELSEVIER
Article

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)

  • Kim, Jin Seok
  • Song, Yang
  • Jen, Wei-Ying
  • Chim, C. S.
  • Lee, Je-Jung
  • ... Lee, Jae Hoon
  • 외 16명
  • 2025-10
  • Blood Cancer Journal
  • SPRINGERNATURE
1